Skip to main content
DAWN
NASDAQ Life Sciences

Servier 完成 25 亿美元收购 Day One Biopharmaceuticals

feedReported by Dow Jones Newswires
Sentiment info
Positive
Importance info
8
Price
$21.5
Mkt Cap
$2.225B
52W Low
$5.635
52W High
$21.53
Market data snapshot near publication time

summarizeSummary

Servier 已成功完成对 Day One Biopharmaceuticals 的收购要约,收购价格为每股 21.50 美元,代表着大约 25 亿美元的总股权价值。这完成了之前宣布的收购过程,这在最近的 SEC 文件中是显而易见的,包括一份 Schedule 13D/A 显示主要股东交割他们的股份,以及 SC TO-T/A 和 SC 14D9/A 文件披露股东诉讼挑战这笔交易。市场已经基本上对这笔收购进行了定价,DAWN 股票以接近收购价格的价格交易。这次收购的完成意味着 Day One Biopharmaceuticals 将不再是一家独立的公开交易实体。交割股份的股东将获得约定的现金补偿,标志着投资者的最终退出。下一步将是 Day One Biopharmaceuticals 股票从 NASDAQ 退市。

在该公告发布时,DAWN的交易价格为$21.50,交易所为NASDAQ,所属行业为Life Sciences,市值约为$22.2亿。 52周交易区间为$5.64至$21.53。 这则新闻被评估为积极市场情绪,重要性评分为8/10。 来源:Dow Jones Newswires。


show_chartPrice Chart

Share this article

Copied!

feed DAWN - Latest Insights

DAWN
Apr 23, 2026, 8:57 AM EDT
Filing Type: POSASR
Importance Score:
7
DAWN
Apr 23, 2026, 8:55 AM EDT
Filing Type: POSASR
Importance Score:
7
DAWN
Apr 23, 2026, 8:54 AM EDT
Filing Type: 8-K
Importance Score:
10
DAWN
Apr 23, 2026, 8:39 AM EDT
Filing Type: SC 14D9/A
Importance Score:
10
DAWN
Apr 23, 2026, 8:31 AM EDT
Filing Type: SC TO-T/A
Importance Score:
10
DAWN
Apr 23, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
DAWN
Apr 17, 2026, 4:00 PM EDT
Filing Type: 10-K/A
Importance Score:
7
DAWN
Apr 14, 2026, 6:03 AM EDT
Filing Type: SC 14D9/A
Importance Score:
8
DAWN
Apr 14, 2026, 6:02 AM EDT
Filing Type: SC TO-T/A
Importance Score:
8
DAWN
Apr 13, 2026, 5:06 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8